Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Alpha-Klotho messenger RNA (KL mRNA) is the transcript of the KL gene, which encodes the alpha-Klotho protein, a critical regulator of aging and mineral metabolism [UniProt Q9UEF7]. Primarily expressed in the renal distal convoluted tubules and the choroid plexus of the brain, Klotho acts as an essential co-receptor for fibroblast growth factor 23 (FGF23) to maintain phosphate and vitamin D homeostasis [Nature Reviews Nephrology, 2019]. Beyond its role in mineral metabolism, Klotho functions as a circulating hormone with potent anti-oxidative, anti-inflammatory, and anti-senescence properties [JASN, 2011]. A decline in Klotho expression is a hallmark of chronic kidney disease (CKD) and is associated with accelerated aging, cardiovascular complications, and cognitive decline [Nature Reviews Nephrology, 2009]. Therapeutic approaches utilizing Klotho-encoding mRNA aim to restore endogenous protein levels through transient expression, offering a potential strategy to mitigate the progression of age-related and metabolic diseases [Molecular Therapy, 2020]. This modality is particularly attractive because it avoids the genomic integration risks associated with DNA-based gene therapy while providing the necessary protein for systemic or local action. Current research focuses on optimizing lipid nanoparticle (LNP) delivery systems to target the kidneys or liver for sustained protein secretion.
Translation of exogenous mRNA into functional alpha-Klotho protein to restore physiological signaling and cytoprotective functions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Alpha-Klotho messenger RNA (KL mRNA) (KL mRNA).